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Which attenuation coefficient to use
in combined attenuation and scatter 
corrections for quantitative brain SPET?
Dear Sir,
We read with interest the recent paper by Shiga et al.
published in the European Journal of Nuclear Medicine
[1]. The authors report some interesting results concern-
ing the effect of triple-energy window-based scatter cor-
rection on brain perfusion SPET using statistical para-
metric mapping (SPM) analysis. The research performed
is worthwhile and contributes significantly to our under-
standing of the effect of scatter correction; to the best of
our knowledge, it is also the first time that SPM analysis
has been used for this purpose instead of conventional
qualitative and region of interest (ROI)-based quantita-
tive evaluations [2]. However, we feel that certain rele-
vant issues were not sufficiently addressed by the au-
thors, and we would like to make some comments on
this work.
The variety of pertinent publications in this field em-
phasises the importance of methodological consider-
ations. Unfortunately, there are a considerable number of
references relating to the subject that were not cited in
the paper (e.g. [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13]). In our
opinion, the reader would have gained a clearer picture
of research performed in the field if these references had
been cited and discussed. Firstly, the way in which the
authors perform combined attenuation and scatter correc-
tion is not well elucidated in the Materials and methods
section. There seems to be a misunderstanding regarding
the choice of the linear attenuation coefficient to be ap-
plied during attenuation correction in brain SPET stud-
ies. It is well known that while attenuation decreases the
number of photons which can be acquired from a source,
scatter will add photons. Correction of simply the num-
ber of detected photons can be performed using lower
values for the narrow-beam attenuation coefficient [5]
(e.g., µ=0.10–0.12 cm–1 rather than µ=0.15 cm–1 for
99mTc-labelled compounds), the most appropriate choice
being dependent on the energy window setting. This em-
pirical approach was often implemented in commercial
systems in the 1990s and is considered to be an intrinsic
scatter correction procedure [14]. A slightly lower value
of the attenuation coefficient is used for the following
reason. The full value of µ predicts how many photons
will be removed from a single, narrow beam of radiation
owing to the combined processes of absorption and scat-
ter. It ignores the number of photons that can be scat-
tered into the path from other directions. That is, it ig-
nores the build-up caused by the broad-beam conditions
of nuclear medicine imaging. Use of the actual narrow-
beam value of µ without explicitly correcting for scatter
will overcorrect for attenuation, and an image excessive-
ly hot in the centre will result. Although images may be
cosmetically enhanced, improvements in image quantita-
tion are only minimal with the reduced μ method of scat-
ter correction. This is because this method assumes that
scatter affects all locations in the image to the same ex-
tent. However, scatter is object and depth dependent, and
a correction method which does not take this fact into
account may result in large quantitation errors [15].
On the other hand, the skull thickness influences the
mean effective broad-beam attenuation coefficient (µeff)
by a paradoxical lowering [16]. The attenuation of the
skull has been evaluated by many investigators [3, 7,
10], all of whom have suggested the use of a lower value
of µeff than for a uniform soft tissue medium. The choice
of the “optimal value” of the linear attenuation coeffi-
cient was studied in an elegant paper by Kemp et al. [3],
where the use of effective bone and tissue attenuation
coefficients to compensate 99mTc-HMPAO brain SPET
projections for attenuation resulted in images of im-
proved uniformity and increased count density. In anoth-
er study using an anthropomorphic phantom, the “best”
choice of the effective linear attenuation coefficient was
found to be slice dependent and reliant on the skull
thickness and the methods used for attenuation and scat-
ter corrections [4]. The deviation from the theoretical
value of 0.15 cm–1 may, in all cases, be explained by
non-optimal scatter corrections.
The theoretical narrow-beam attenuation coefficient is
0.148 cm–1 for the 159-keV gamma rays of 123I in water
[17]. In Shiga et al.’s study, a value of 0.146 cm–1 was
used, as reported in [18], for scatter-corrected images
and a value of 0.10 cm–1 for images without scatter cor-
rection, a choice motivated according to the authors by a
phantom study without further rationale and justification
[1]. Van Laere et al. [9] used an attenuation coefficient of
1.05 cm–1 determined from experimental studies using
the 3D Hoffman brain phantom and 0.09 cm–1 for clini-
cal studies [10], indicating that results obtained from
phantom studies cannot be extrapolated directly for ap-
plication to human data.
With respect to the title of the paper, the reader would
expect an investigation of the effect of scatter correction
on regional activity distribution of brain perfusion SPET
using SPM analysis, whereas from the description pro-
vided, it looks as if two scatter correction schemes are
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compared, i.e. the empirical reduced μ method and the
energy-based scatter correction method. If the motiva-
tion is to assess the effect of scatter correction, the rea-
sons for modifying the linear attenuation coefficient be-
tween the two data sets are not clear.
The other aspect that deserves special attention is the
choice of the attenuation correction method. It is gener-
ally well accepted that transmission-based non-uniform
attenuation correction can supply more accurate absolute
quantification; however, whether it provides specific
benefits in the routine clinical practice of functional
brain imaging is still the subject of debate [10, 19].
Some authors have reported that uniform attenuation-
corrected studies provide unreliable regional estimates of
tracer activity [6]. Others, using Monte Carlo simulation
studies of the Zubal brain phantom, have shown that an
accurate attenuation map is crucial for absolute quantita-
tion, but less of an issue in relative quantitation in brain
SPET [20]. In the Discussion section, Shiga et al. con-
sidered the various methods that may be used for attenu-
ation correction and argue that the attenuation map will
have only a minimal effect on the conclusions drawn
from their study. They recognise that transmission-based
attenuation correction is the clinical “gold standard”
without offering further comments on the reasons why it
was not used in their study. Moreover, estimation of the
attenuation map from a segmented reconstruction of a
lower-energy Compton scatter window image was re-
ported as the next most accurate clinical method and can
be reliably used when transmission scanning cannot be
used [6].
The other concern is related to the energy window
settings for application of the triple-energy scatter cor-
rection technique. As the authors point out, this method
increases the noise and it is well known that SPM analy-
sis is very sensitive to statistical noise. A Monte Carlo
investigation of the method by Ljungberg et al. [21]
questioned the utility of the upper (right) scatter window
for 99Tc, noting that using the right scatter window might
make the TEW method more susceptible to noise. In a
related study, it has been shown that the scatter compo-
nent is overestimated by 18% when both windows are
used and underestimated by 14% when only the lower
window is used [22]. Neglecting the higher scatter win-
dow has also been recommended to avoid increasing sta-
tistical noise [23]. The energy settings used in the study
by Shiga et al. were 160 keV peak with 24% width for
the main window and 3% width for the scatter rejection
window. This means that the upper scatter rejection win-
dow was neglected, an assumption with proven validity
for 99mTc but not for 123I [18]. The optimal choice of the
acquisition window for 123I-labelled compounds taking
into account its decay scheme and the impact of down-
scatter from high-energy photons (e.g. 520 keV) was not
addressed and deserves further discussion as well.
In summary, we want to stress the importance of at-
tenuation and scatter corrections on regional activity dis-
tribution in quantitative brain SPET and the need for rig-
our in describing the methods used so as to ensure both
the clarity and the reproducibility of published work.
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gion of interest analysis. In our paper, we compared im-
ages obtained using (a) Chang’s attenuation correction
method [uniform µ map using a broad µ value
(0.10 cm–1)] without scatter correction, and (b) Chang’s
attenuation correction method [uniform µ map using a
narrow µ value (0.146 cm–1)] with triple energy window
scatter correction.
Another misunderstanding of Drs. Zaidi and Montan-
don is that the upper scatter rejection window was ne-
glected. We applied the triple energy window (TEW)
scatter correction method in our study, not the dual win-
dow method. We used three energy windows: one main
window and upper and lower scatter rejection windows.
In fact, the upper rejection window may be neglected on
condition that a 99mTc-labelled agent is used [3]. Buvat et
al. reported that the TEW method leads to overestima-
tion when using 99mTc [4]. In our study, we used 123I-
IMP and the aforementioned findings were therefore in-
applicable; accordingly, we did not refer to those papers.
As already indicated, for attenuation correction we
applied Chang’s method. It is the best way of correcting
images with a µ map obtained from the transmission
scan. However, as described by Licho et al. [5], the
transmission imaging technique produces an estimate of
the narrow-beam attenuation coefficient map. Therefore,
scatter correction of emission data is necessary. Attenua-
tion correction with the measured µ map definitely leads
to overcorrection, especially in the central part of ob-
jects, without scatter correction. On the other hand, Iida
et al. [2] reported that reconstruction using a uniform µ
attenuation map and a narrow µ with scatter correction
could be used to assess regional cerebral blood flow with
little loss of accuracy in most brain regions. In our study,
since we compared images with and without scatter cor-
rection, conditions had to be matched as closely as possi-
ble. Therefore, we chose Chang’s attenuation correction
method. However, without transmission, errors may oc-
cur when determining the contour of the constant µ at-
tenuation map. In this study, since the contour of the
constant µ attenuation map was determined using emis-
sion data both with and without scatter correction, the
contour was almost same between the two images. As
we described, two images were compared within each
subject. The errors that were derived from the uniform µ
map made from almost the same contour of those two
images were considered to be almost the same. There-
fore, the errors should have been cancelled out in the sta-
tistical procedure.
Licho et al. [5] reported the estimation of an attenua-
tion map from segmented reconstruction of a low-energy
Compton scatter window image when using 99mTc-
HMPAO SPET. We used 123I-IMP for brain perfusion
SPET, and to our knowledge there has been no report on
the optimal window range and energy peak for estima-
tion of the attenuation map with 123I-IMP brain perfusion
SPET. We therefore thought that the application of the
aforementioned method to our study was not appropriate.
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Reply
Dear Sir,
We read with interest the letter from Drs. Zaidi and
Montandon. We appreciate their valuable comments, but
there seems to have been a lot of misunderstanding re-
garding our paper.
First, the aim of our study was to investigate the dif-
ference in 123I-IMP distribution using brain perfusion
SPET with and without scatter correction, not to investi-
gate the quantitative difference between them [1]. As
mentioned in the Introduction to our paper, there is an
excellent paper by Iida et al. [2] on the quantitative dif-
ference in regional cerebral blood flow with different
scatter and attenuation correction methods based on re-
